1.2

NEXTGEN DIGITAL ANNOUNCES UPSIZE OF NON-BROKERED PRIVATE PLACEMENT TO $1.2 MILLION & PURCHASE OF XRP COINSNEXTGEN DIGITAL ANNOUNCES UPSIZE OF NON-BROKERED PRIVATE PLACEMENT TO $1.2 MILLION & PURCHASE OF XRP COINS

NEXTGEN DIGITAL ANNOUNCES UPSIZE OF NON-BROKERED PRIVATE PLACEMENT TO $1.2 MILLION & PURCHASE OF XRP COINS

– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES – January 29, 2025 02:00 ET  |…

2 months ago
Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin LymphomaGalapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Data from the ongoing Phase 1/2 ATALANTA-1 study in a heavily pretreated R/R NHL patient population demonstrate high antitumor activity…

3 months ago
Roquette Successfully Completes Inaugural EUR 1.2 billion Bond Offering to Support its Transformative Acquisition of IFF Pharma SolutionsRoquette Successfully Completes Inaugural EUR 1.2 billion Bond Offering to Support its Transformative Acquisition of IFF Pharma Solutions

Roquette Successfully Completes Inaugural EUR 1.2 billion Bond Offering to Support its Transformative Acquisition of IFF Pharma Solutions

Roquette Successfully Completes Inaugural EUR 1.2 billion Bond Offering to Support its Transformative Acquisition of IFF Pharma Solutions Lille, 26th…

4 months ago